The Post-ASH 2020 Virtual iwAL Workshop took place between the 21st and 22nd of January 2021 with VJHemOnc as an official media partner.
This workshop highlighted key data in acute leukemias presented at the annual ASH 2020 meeting and featured important discussions on translating results into clinical practice.
Topics covered include MRD, CAR T-cell therapies and immunotherapy in ALL, and immunotherapy, FLT3, novel therapies, and controversies in AML.
By choosing to continue, you are confirming that you are a healthcare professional
Keep up to date with all the latest news with our monthly newsletter